Skip to main content
Premium Trial:

Request an Annual Quote

Pac Bio Proof-of-Concept Paper Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 21.
1) Pac Bio Publishes Proof-of-Concept Paper on Single-Molecule Sequencing Technology (from Nov. 20)
2) Illumina to Seek FDA Clearance, CLIA Certification in '09 (from Nov. 17)
3) ABI Shareholders Overwhelmingly Elect to Receive Cash in Merger (from Nov. 20)
4) Life Technologies, Bio-Rad to Join S&P Indexes (from Nov. 18)
5) International Cancer Genome Consortium Announces Eight New Projects (from Nov. 19)
The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.